Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandra Wymann

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Biomolecules|October 28, 2023
The Molecular Mechanisms of Complement Receptor 1-It Is ComplicatedMatthew P Hardy, Mariam Mansour, Tony Rowe, et al.
Transfusion|July 16, 2015
Donor screening reduces the isoagglutinin titer in immunoglobulin productsBrigitte Siani, Katharina Willimann, Sandra Wymann, et al.
Biologics in Therapy|May 21, 2014
Isoagglutinin Reduction in Human Immunoglobulin Products by Donor ScreeningBrigitte Siani, Katharina Willimann, Sandra Wymann, et al.
Plos One|June 8, 2012
Analysis and functional consequences of increased Fab-sialylation of intravenous immunoglobulin (IVIG) after lectin fractionationFabian Käsermann, David J Boerema, Monika Rüegsegger, et al.
Molecular Immunology|February 19, 2008
Monomerization of dimeric IgG of intravenous immunoglobulin (IVIg) increases the antibody reactivity against intracellular antigensSandra Wymann, Marco Ghielmetti, Alexander Schaub, et al.
Annals of the New York Academy of Sciences|October 4, 2007
Self-reactivity in the dimeric intravenous immunoglobulin fractionAlexander Schaub, Sandra Wymann, Manfred Heller, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|September 21, 2016
Reduction of Isoagglutinin in Intravenous Immunoglobulin (IVIG) Using Blood Group A- and B-Specific Immunoaffinity Chromatography: Industry-Scale AssessmentSimon Gerber, Annette Gaida, Nicole Spiegl, et al.
Frontiers in Immunology|March 30, 2017
Monomeric Immunoglobulin A from Plasma Inhibits Human Th17 Responses <i>In Vitro</i> Independent of FcαRI and DC-SIGNChaitrali Saha, Mrinmoy Das, Veerupaxagouda Patil, et al.
International Journal of Molecular Sciences|June 26, 2026
In Vivo Efficacy of an Inhibitor of Complement and FcRn in Models of Glomerulonephritis and Collagen-Induced Arthritis Using Human C2 Knock-In MiceHelen Cao, Amelia Nash, Yun Dai, et al.
The Journal of Biological Chemistry|June 6, 2024
Mechanistic insights into complement pathway inhibition by CR1 domain duplicationSandra Wymann, Anup G Nair, Svenja Ewert, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Biomolecules|October 28, 2023
The Molecular Mechanisms of Complement Receptor 1-It Is ComplicatedMatthew P Hardy, Mariam Mansour, Tony Rowe, et al.
Transfusion|July 16, 2015
Donor screening reduces the isoagglutinin titer in immunoglobulin productsBrigitte Siani, Katharina Willimann, Sandra Wymann, et al.
Biologics in Therapy|May 21, 2014
Isoagglutinin Reduction in Human Immunoglobulin Products by Donor ScreeningBrigitte Siani, Katharina Willimann, Sandra Wymann, et al.
Plos One|June 8, 2012
Analysis and functional consequences of increased Fab-sialylation of intravenous immunoglobulin (IVIG) after lectin fractionationFabian Käsermann, David J Boerema, Monika Rüegsegger, et al.
Molecular Immunology|February 19, 2008
Monomerization of dimeric IgG of intravenous immunoglobulin (IVIg) increases the antibody reactivity against intracellular antigensSandra Wymann, Marco Ghielmetti, Alexander Schaub, et al.
Annals of the New York Academy of Sciences|October 4, 2007
Self-reactivity in the dimeric intravenous immunoglobulin fractionAlexander Schaub, Sandra Wymann, Manfred Heller, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|September 21, 2016
Reduction of Isoagglutinin in Intravenous Immunoglobulin (IVIG) Using Blood Group A- and B-Specific Immunoaffinity Chromatography: Industry-Scale AssessmentSimon Gerber, Annette Gaida, Nicole Spiegl, et al.
Frontiers in Immunology|March 30, 2017
Monomeric Immunoglobulin A from Plasma Inhibits Human Th17 Responses <i>In Vitro</i> Independent of FcαRI and DC-SIGNChaitrali Saha, Mrinmoy Das, Veerupaxagouda Patil, et al.
International Journal of Molecular Sciences|June 26, 2026
In Vivo Efficacy of an Inhibitor of Complement and FcRn in Models of Glomerulonephritis and Collagen-Induced Arthritis Using Human C2 Knock-In MiceHelen Cao, Amelia Nash, Yun Dai, et al.
The Journal of Biological Chemistry|June 6, 2024
Mechanistic insights into complement pathway inhibition by CR1 domain duplicationSandra Wymann, Anup G Nair, Svenja Ewert, et al.
Pageof 2